FoU Spenshult

2016-04-18

Evaluation of the association between anticarbamylated protein antibodies and the longitudinal course of functional ability in rheumatoid arthritis.

Ajeganova S, Svensson B, Huizinga TW, van der Helm-van Mil AH, van Steenbergen HW.Ann Rheum Dis. 2016 Apr;75(4):e14. doi: 10.1136/annrheumdis-2015-208954. Epub 2015 Dec 23.PMID: 26698847

2016-03-21

European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update.

Gossec L, Smolen JS, Ramiro S, de Wit M, Cutolo M, Dougados M, Emery P, Landewé R, Oliver S, Aletaha D, Betteridge N, Braun J, Burmester G, Cañete JD, Damjanov N, FitzGerald O, Haglund E, Helliwell P, Kvien TK, Lories R, Luger T, Maccarone M, Marzo-Ortega H, McGonagle D, McInnes IB, Olivieri I, Pavelka K, Schett G, Sieper J, van den Bosch F, Veale DJ, Wollenhaupt J, Zink A, van der Heijde D.

Ann Rheum Dis. 2016 Mar;75(3):499-510. doi: 10.1136/annrheumdis-2015-208337. Epub 2015 Dec 7.

PMID: 26644232

2016-03-01

Association of a multibiomarker disease activity score at multiple time-points with radiographic progression in rheumatoid arthritis: results from the SWEFOT trial.

Hambardzumyan K, Bolce RJ, Saevarsdottir S, Forslind K, Wallman JK, Cruickshank SE, Sasso EH, Chernoff D, van Vollenhoven RF. RMD Open. 2016 Mar 1;2(1):e000197.

2016-02-27

Back pain and health status in patients with clinically diagnosed ankylosing spondylitis, psoriatic arthritis and other spondyloarthritis: a cross-sectional population-based study.

Lindström U, Bremander A, Haglund E, Bergman S, Petersson IF, Jacobsson LT.

BMC Musculoskelet Disord. 2016 Feb 27;17:106. doi: 10.1186/s12891-016-0960-8.

PMID: 26922375

2016-02-25

Changes in the anticitrullinated peptide antibody response in relation to therapeutic outcome in early rheumatoid arthritis: results from the SWEFOT trial.

Kastbom A, Forslind K, Ernestam S, Geborek P, Karlsson JA, Petersson IF, Saevarsdottir S, Klareskog L, van Vollenhoven RF, Lundberg K. Ann Rheum Dis. 2016 Feb;75(2):356-61.

2016-02-24

Spinal Mobility in Axial Spondyloarthritis: A Cross-Sectional Clinical Study.

Mogard E, Lindqvist E, Bergman S, Bremander A.

Musculoskeletal Care. 2017 Mar;15(1):36-48. doi: 10.1002/msc.1138. Epub 2016 Feb 24.

PMID: 26916253

2016-01-28

MRI evidence of persistent joint inflammation and progressive joint damage despite clinical remission during treatment of early rheumatoid arthritis.

Forslind K, Svensson B. Scand J Rheumatol. 2016;45(2):99-102.

2016-01-14

A multicentre, randomised, controlled, open-label pilot study on the feasibility of discontinuation of adalimumab in established patients with rheumatoid arthritis in stable clinical remission.

Chatzidionysiou K, Turesson C, Teleman A, Knight A, Lindqvist E, Larsson P, Cöster L, Forslind K, van Vollenhoven R, Heimbürger M. RMD Open. 2016 Jan 14;2(1):e000133.

2016-01-12

Anticitrullinated protein antibodies and rheumatoid factor are associated with increased mortality but with different causes of death in patients with rheumatoid arthritis: a longitudinal study in three European cohorts.

Ajeganova S, Humphreys JH, Verheul MK, van Steenbergen HW, van Nies JA, Hafström I, Svensson B, Huizinga TW, Trouw LA, Verstappen SM, van der Helm-van Mil AH.Ann Rheum Dis. 2016 Nov;75(11):1924-1932. doi: 10.1136/annrheumdis-2015-208579. Epub 2016 Jan 12.PMID: 26757747

2016

Adress

Kontakt